UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Novel Hsp90 inhibitor platycodin D disrupts Hsp90/Cdc37 complex and enhances the anticancer effect of mTOR inhibitor Journal article
Li, Ting, Chen, Xin, Dai, Xiao-Yang, Wei, Bin, Weng, Qin-Jie, Chen, Xiuping, Ouyang, De-Fang, Yan, Ru, Huang, Zhang-Jian, Jiang, Hu-Lin, Zhu, Hong, Lu, Jin-Jian. Novel Hsp90 inhibitor platycodin D disrupts Hsp90/Cdc37 complex and enhances the anticancer effect of mTOR inhibitor[J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 2017, 330, 65-73.
Authors:  Li, Ting;  Chen, Xin;  Dai, Xiao-Yang;  Wei, Bin;  Weng, Qin-Jie; et al.
Favorite | TC[WOS]:31 TC[Scopus]:31  IF:3.3/3.6 | Submit date:2018/10/30
Everolimus  Platycodin d  Hsp90  Cdc37  Egfr  Igf1r  
Platycodin D, a novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex, enhances the anti-cancer effect of mTOR inhibitor Conference paper
Li, T, Chen, X, Dai, XY, Wei, B, Weng, QJ, Chen, X. P., Ouyang, D., Yan, R., Huang, ZJ, Jiang, HL, Zhu, H, Lu, J.. Platycodin D, a novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex, enhances the anti-cancer effect of mTOR inhibitor[C], 2017.
Authors:  Li, T;  Chen, X;  Dai, XY;  Wei, B;  Weng, QJ; et al.
Favorite |  | Submit date:2022/08/26
Everolimus  platycodin D  Hsp90  Cdc37  EGFR  IGF1R